Regimen durability in HIV-infected children and adolescents initiating first-line antiretroviral therapy in a large public sector HIV cohort in South Africa

By Rachael Bonawitz  Dr. Alana Brennan  Dr. Lawrence Long  Timothy Heeren  Dr Mhairi Maskew  Professor Ian Sanne  Dr. Matthew Fox  |  | 

The decline in single-drug substitutions is associated with the introduction of Tenofovir. Tenofovir use could improve regimen durability and treatment outcomes in resource-limited settings.

Publication details

Tropical Medicine and International Health